解放军药学学报2024,Vol.37Issue(4) :299-303.DOI:10.3969/j.issn.1008-9926.2024.04.001

我国基本药物制度现状、问题与展望

Challenges and Prospects of Essential Medicine System in China

蒯丽萍 张晓东
解放军药学学报2024,Vol.37Issue(4) :299-303.DOI:10.3969/j.issn.1008-9926.2024.04.001

我国基本药物制度现状、问题与展望

Challenges and Prospects of Essential Medicine System in China

蒯丽萍 1张晓东2
扫码查看

作者信息

  • 1. 100040 北京,中国医药企业管理协会
  • 2. 100020 北京,中国药学会
  • 折叠

摘要

2009年以来,国家卫生行政管理部门通过颁布系列法规制度,遴选并调整了多版基本药物目录,初步建立了我国基本药物制度,为提升药品供应保障能力发挥了重要作用.随着医疗卫生体制改革的不断深入,人民群众用药需求也发生了较大变化,药品供应保障体系相关政策相继颁布实施,我国基本药物制度也面临新的问题与挑战.本文回顾了 2009年以来我国基本药物制度建立与实施的基本情况,通过分析基本药物制度当前面临的形势与问题,对未来该制度的优化与调整提出建议.

Abstract

Since 2009,the state health administrative departments have issued a series of laws and regulations,selected and adjusted multiple editions of the essential medicine list,and preliminarily estab-lished essential medicine systems,which has played a significant role in improving the drug supply in China.Along with the healthcare reform,the needs of the general public for medicines have also changed drastically.Other related policies for the drug supply system have been successively promulgated and implemented,but the system for essential medicines is facing many problems and challenges.The establishment and implementation of essential medicine systems since the start of healthcare reform in 2009 were reviewed,the status quo and problems were analyzed,and corresponding countermeasures for the optimization and adjustment of the system were put forward in this paper.

关键词

基本药物制度/基本药物目录/国家药物政策

Key words

essential medicine system/essential medicine list/national drug policy

引用本文复制引用

出版年

2024
解放军药学学报
中国人民解放军总后勤部卫生部 药品仪器检验所

解放军药学学报

CSTPCD
影响因子:0.529
ISSN:1008-9926
参考文献量2
段落导航相关论文